Scientists at Cornell’s college of Veterinary Medicine have developed a vaccine for Johne’s disease, a condition that leads to $220 million to $250 million in losses annually to the U.S. dairy industry. Through their research, the Cornell team identified and prepared the antigen necessary for the vaccine development. Their antigen is licensed to the Biotechnology Research and Development Corp.

The research was published in the January issue of the journal Vaccine. To access it, click here.